Union Health Minister reviews availability of COVID essential drugs, buffer stocks

The strategic buffer stock has been created for 8 drugs, all of these are available in the country.

Published On 2021-09-02 07:14 GMT   |   Update On 2021-09-02 07:14 GMT

New Delhi: Union Minister for Health and Family Welfare and Chemicals and Fertilisers, Mansukh Mandaviya reviewed the supply and availability of COVID-19 related essential medicines in the country.During the review, it was noted that sufficient stocks of all the essential medicines are available. Raw materials for these drugs are also available in enough quantities.Also Read: Union...

Login or Register to read the full article

New Delhi: Union Minister for Health and Family Welfare and Chemicals and Fertilisers, Mansukh Mandaviya reviewed the supply and availability of COVID-19 related essential medicines in the country.

During the review, it was noted that sufficient stocks of all the essential medicines are available. Raw materials for these drugs are also available in enough quantities.

The strategic buffer stock has been created for 8 drugs, all of these are available in the country. Here is the list of 8 drugs:

1. Tocilizumab

2. Methyl Predinisolone

3. Enaxopirin

4. Dexamethasone

5. Remdesivir

6. Amphotericin B Deoxycholate

7. Posaconazole

8. Intravenous Immunoglobilin (IVIG)

Senior Officials of the Ministry of Health and Family Welfare were present in the review meeting.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News